Effect of Acoramidis on Recurrent and Cumulative Cardiovascular Outcomes in ATTR-CM

Acoramidis significantly reduced the cumulative burden of CV outcomes in ATTR-CM over 30 months. Numerically fewer events were observed with acoramidis vs placebo by month 1, and the difference increased progressively over time, resulting in 53 events avoided per 100 treated patients at month 30. Almost one-fourth of the cumulative CV events occurred within the first 6 months. These exploratory findings suggest that cumulative event burden may occur early, highlighting the importance of timely evaluation, diagnosis and treatment in ATTR-CM.

Authors

Institutions

Publication Details

Journal
Journal of the American College of Cardiology
Published
2025-09-28
DOI
https://doi.org/10.1016/j.jacc.2025.09.013
Citations
3
Primary Topic
Frailty in Older Adults
Type
article
Field-Weighted Citation Impact
3.67
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effect of Acoramidis on Recurrent and Cumulative Cardiovascular Outcomes in ATTR-CM

Adam Castaño, Frederick L. Ruberg, Ronald Witteles, Suresh Siddhanti et al.
3 citations
Journal of the American College of Cardiology
Frailty in Older Adults
3.67
article

Effect of Acoramidis on Recurrent and Cumulative Cardiovascular Outcomes in ATTR-CM

Adam Castaño, Frederick L. Ruberg, Ronald Witteles, Suresh Siddhanti, Richard Kar-Hang Cheng, Steen Hvitfeldt Poulsen, Justin L. Grodin, Sarah Cuddy, Kuangnan Xiong, Gillian Murtagh, Julian D. Gillmore, Amrut V. Ambardekar, Matthew J. Maurer, Ahmad Masri, Laura Piera Obici, Daniel Philip Judge, Kevin Michael Alexander, Peter van der Meer, Jean‐François Tamby, Xiaofan Cao, Jonathan C. Fox
article en
3 citations

Abstract

Acoramidis significantly reduced the cumulative burden of CV outcomes in ATTR-CM over 30 months. Numerically fewer events were observed with acoramidis vs placebo by month 1, and the difference increased progressively over time, resulting in 53 events avoided per 100 treated patients at month 30. Almost one-fourth of the cumulative CV events occurred within the first 6 months. These exploratory findings suggest that cumulative event burden may occur early, highlighting the importance of timely evaluation, diagnosis and treatment in ATTR-CM.

Journal of the American College of CardiologyVol. 87(5)
Boston University (US), Brigham and Women's Hospital (US), Boston Medical Center (US), Parkland Health & Hospital System (US), University Medical Center Groningen (NL), Medical University of South Carolina (US), Oregon Health & Science University (US), University of Groningen (NL), University of Washington (US), Columbia University Irving Medical Center (US), The Royal Free Hospital (GB), Aarhus University Hospital (DK), BridgeBio (United States) (US), Stanford Medicine (US), Bridge Pharma (United States) (US), University College London (GB), University of Colorado Anschutz Medical Campus (US), University of Colorado Denver (US), Stanford University (US)
Openalex Percentile: Top 6%
Frailty in Older Adults
3.67
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.